VFA
RPTP

Virtus Fund Advisers’s RAPTOR PHARMACEUTICAL CORP COM STK (DE) RPTP Stock Holding History

Virtus Fund Advisers’s Portfolio RPTP Stock Details RPTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-5,343
Closed -$62K – 2820
2014
Q2 		$62K Buy
+5,343
New +$48.6K ﹤0.01% 1729

Other funds holding RPTP

CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Virtus Fund Advisers's RPTP Position: Q3 2014 in Review

Virtus Fund Advisers sold out of RAPTOR PHARMACEUTICAL CORP COM STK (DE) (RPTP) in Q3 2014, closing a stake of 5,343 shares — an estimated $62K sold.

Virtus Fund Advisers first reported a position in RPTP in Q2 2014 and held it in 1 quarter. The position peaked at $62K in Q2 2014. 82 funds tracked by Wall St. Rank hold RPTP as of Q3 2014.

  • Virtus Fund Advisers reported no remaining RAPTOR PHARMACEUTICAL CORP COM STK (DE) position as of Q3 2014 after selling out during the quarter.
  • Virtus Fund Advisers sold 5,343 RAPTOR PHARMACEUTICAL CORP COM STK (DE) shares in Q3 2014, an estimated $62K.
  • Virtus Fund Advisers first reported a position in RAPTOR PHARMACEUTICAL CORP COM STK (DE) in Q2 2014 and held it in 1 quarter.
  • Virtus Fund Advisers's RAPTOR PHARMACEUTICAL CORP COM STK (DE) position peaked at $62K in Q2 2014.
  • 82 funds tracked by Wall St. Rank held RAPTOR PHARMACEUTICAL CORP COM STK (DE) as of Q3 2014.

Based on Virtus Fund Advisers's 13F filing for Q3 2014, filed 31 Oct 2014.